Sign In
Buy C
$135.13
+5.14 (+3.95%)
At Close: Jun 04, 2026
Citigroup (C) Reports Next Week: Wall Street Expects Earnings Growth
11:06am, Wednesday, 08'th Jan 2025
Citigroup (C) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Citigroup Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
03:00am, Wednesday, 08'th Jan 2025
Citigroup Inc. C will release its fourth-quarter financial results before the opening bell on Wednesday, Jan. 15.
Why the Market Dipped But Citigroup (C) Gained Today
07:16pm, Tuesday, 07'th Jan 2025
In the most recent trading session, Citigroup (C) closed at $73.68, indicating a +1.29% shift from the previous trading day.
Citigroup Touches 52-Week High: Should Investors Buy C Stock Now?
12:57pm, Tuesday, 07'th Jan 2025
C Stock reaches 52-week high. Can the bank's transformational efforts and the Fed's recent rate cuts keep the momentum?
How To Earn $500 A Month From Citigroup Stock Ahead Of Q4 Earnings
08:21am, Tuesday, 07'th Jan 2025
Citigroup Inc. C will release its fourth-quarter financial results before the opening bel l on Wednesday, Jan. 15.
The Magnificent 7 Blue-Chip Dividend Stocks to Buy in 2025 and Hold Forever
05:41pm, Monday, 06'th Jan 2025
Large-capitalization blue-chip dividend stocks are a favorite among investors for a good reason.
Citigroup's stock is a banking-sector bargain as ‘inflection point' looms, analyst suggests
08:08am, Monday, 06'th Jan 2025
Barclays analyst Jason Goldberg upgrades Citigroup to overweight from equal weight on bullish 2025 prospects.
5 Predictions for the Stock Market in 2025 -- and Which Stocks Will Soar the Most If They're Right
05:46am, Saturday, 04'th Jan 2025
Nearly one year ago, I made four predictions about the stock market in 2024. I thought the S&P 500 would generate positive returns but lower than in 2023.
Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
04:00pm, Friday, 03'rd Jan 2025
SOUTH SAN FRANCISCO, Calif., Jan. 03, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 31, 2024 it granted stock options to purchase an aggregate of
Wells Fargo names Citi 'dominant pick', predicts stock to double in three years
10:51am, Friday, 03'rd Jan 2025
Citigroup's stock could double in value over the next three years as the Wall Street lender's profits surge, Wells Fargo analysts wrote in a client note on Friday, naming it the brokerage's top pick i
Wall Street Analysts Think Citigroup (C) Is a Good Investment: Is It?
10:46am, Friday, 03'rd Jan 2025
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often
Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
04:05pm, Thursday, 02'nd Jan 2025
FOSTER CITY, Calif., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio
Stop Trading: Banks aren't expensive and could benefit from regulatory approval
10:46am, Thursday, 02'nd Jan 2025
CNBC's Jim Cramer reports on the financial stocks.
These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar
10:01am, Thursday, 02'nd Jan 2025
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Bank of America and Citigroup exit Net-Zero Banking Alliance amid political pressure
03:22am, Thursday, 02'nd Jan 2025
Bank of America Corp (NYSE:BAC) and Citigroup Inc (NYSE:C) announced their departure from the Net-Zero Banking Alliance, a UN-backed initiative aimed at reducing financial support for industries contr
